von Euler G - Search Results

1

Involvement of cholecystokinin receptors in the control of striatal dopamine autoreceptors.

Tanganelli S, Fuxe K, von Euler G, Agnati LF, Ferraro L, Ungerstedt U. Tanganelli S, et al. Among authors: von euler g. Naunyn Schmiedebergs Arch Pharmacol. 1990 Sep;342(3):300-4. doi: 10.1007/BF00169441. Naunyn Schmiedebergs Arch Pharmacol. 1990. PMID: 2280797

2

Intramembrane interactions between neurotensin receptors and dopamine D2 receptors as a major mechanism for the neuroleptic-like action of neurotensin.

Fuxe K, Von Euler G, Agnati LF, Merlo Pich E, O'Connor WT, Tanganelli S, Li XM, Tinner B, Cintra A, Carani C, et al. Fuxe K, et al. Among authors: von euler g. Ann N Y Acad Sci. 1992;668:186-204. doi: 10.1111/j.1749-6632.1992.tb27350.x. Ann N Y Acad Sci. 1992. PMID: 1361113 Review.

3

Stimulation of high-affinity adenosine A2 receptors decreases the affinity of dopamine D2 receptors in rat striatal membranes.

Ferre S, von Euler G, Johansson B, Fredholm BB, Fuxe K. Ferre S, et al. Among authors: von euler g. Proc Natl Acad Sci U S A. 1991 Aug 15;88(16):7238-41. doi: 10.1073/pnas.88.16.7238. Proc Natl Acad Sci U S A. 1991. PMID: 1678519 Free PMC article.

4

Changes in pituitary-adrenal activity affect the apomorphine- and cholecystokinin-8-induced changes in striatal dopamine release using microdialysis.

Tanganelli S, Fuxe K, von Euler G, Eneroth P, Agnati LF, Ungerstedt U. Tanganelli S, et al. Among authors: von euler g. J Neural Transm Gen Sect. 1990;81(3):183-94. doi: 10.1007/BF01245041. J Neural Transm Gen Sect. 1990. PMID: 2397084

5

Neurotensin modulates the binding characteristics of dopamine D2 receptors in rat striatal membranes also following treatment with toluene.

von Euler G, Fuxe K, Benfenati F, Hansson T, Agnati LF, Gustafsson JA. von Euler G, et al. Acta Physiol Scand. 1989 Apr;135(4):443-8. doi: 10.1111/j.1748-1716.1989.tb08602.x. Acta Physiol Scand. 1989. PMID: 2525310

6

Pertussis toxin treatment counteracts intramembrane interactions between neuropeptide Y receptors and alpha 2-adrenoceptors.

Von Euler G, Fuxe K, Van der Ploeg I, Fredholm BB, Agnati LF. Von Euler G, et al. Eur J Pharmacol. 1989 Dec 5;172(6):435-41. doi: 10.1016/0922-4106(89)90026-6. Eur J Pharmacol. 1989. PMID: 2558898

7

Neurotensin counteracts apomorphine-induced inhibition of dopamine release as studied by microdialysis in rat neostriatum.

Tanganelli S, von Euler G, Fuxe K, Agnati LF, Ungerstedt U. Tanganelli S, et al. Among authors: von euler g. Brain Res. 1989 Nov 20;502(2):319-24. doi: 10.1016/0006-8993(89)90627-6. Brain Res. 1989. PMID: 2819469

8

Neurotensin reduces the affinity of D-2 dopamine receptors in rat striatal membranes.

Von Euler G, Fuxe K. Von Euler G, et al. Acta Physiol Scand. 1987 Dec;131(4):625-6. doi: 10.1111/j.1748-1716.1987.tb08285.x. Acta Physiol Scand. 1987. PMID: 3442244 No abstract available.

9

Neurotensin and cholecystokinin octapeptide control synergistically dopamine release and dopamine D2 receptor affinity in rat neostriatum.

Tanganelli S, Li XM, Ferraro L, Von Euler G, O'Connor WT, Bianchi C, Beani L, Fuxe K. Tanganelli S, et al. Among authors: von euler g. Eur J Pharmacol. 1993 Jan 12;230(2):159-66. doi: 10.1016/0014-2999(93)90798-m. Eur J Pharmacol. 1993. PMID: 8422898

10

Changes in pituitary-adrenal activity affect the binding properties of striatal dopamine D-2 receptors but not their modulation by neurotensin and cholecystokinin-8.

von Euler G, Fuxe K, Tanganelli S, Finnman UB, Eneroth P. von Euler G, et al. Neurochem Int. 1990;16(3):275-80. doi: 10.1016/0197-0186(90)90102-y. Neurochem Int. 1990. PMID: 20504568

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

93 results

Search Page

Filters